Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Antimicrobial Agents|January 1, 1991
Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisitedH H Gadebusch, D L ShunguAntimicrobial Agents and Chemotherapy|July 1, 1986
Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzaeA T Cerami, D L ShunguJournal of Virology|May 1, 1974
Induction of P22 prophage in Salmonella typhimurium by hycanthoneD L Shungu, T M CookJournal of Clinical Microbiology|June 1, 1985
Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenemD L Shungu, E Weinberg, A T CeramiAntimicrobial Agents and Chemotherapy|January 1, 1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogensD L Shungu, E Weinberg, H H GadebuschAntimicrobial Agents and Chemotherapy|February 1, 1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)D L Shungu, E Weinberg, H H GadebuschJournal of Clinical Microbiology|February 1, 1984
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agentsE Weinberg, D L Shungu, H H GadebuschClinical Therapeutics|May 1, 1989
Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniaeD L Shungu, S Ponticas, C J GillEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1989
Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeaeS Ponticas, D L Shungu, C J GillJournal of Clinical Microbiology|October 1, 1983
Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacinD L Shungu, V Tutlane, H H GadebuschPageof 3